Stroke and stroke care in China huge burden, significant workload, and a national priority

Stroke

Volumn 42, Issue 12, 2011, Pages 3651-3654

  Liu, Liping ^a   Wang, David ^b   Lawrence Wong, K S ^c   Wang, Yongjun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cerebrovascular disease; Economics; Risk factors; Stroke care

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; CHOLESTEROL;

AGE DISTRIBUTION; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOT LYSIS; BRAIN ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ANGIOPLASTY; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; CAROTID ENDARTERECTOMY; CHINA; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; CULTURAL FACTOR; DIABETES MELLITUS; DRUG CLASSIFICATION; EDUCATIONAL STATUS; EMERGENCY CARE; EVIDENCE BASED MEDICINE; FAT INTAKE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMOBILIZATION; INCOME; LIFESTYLE; MASS SCREENING; MULTICENTER STUDY (TOPIC); OBESITY; PRIMARY PREVENTION; PRIORITY JOURNAL; RECURRENCE RISK; RURAL AREA; SECONDARY PREVENTION; SMOKING; SOCIAL STATUS; STROKE; URBAN AREA;

AGE FACTORS; AGED; AGED, 80 AND OVER; CHINA; DELIVERY OF HEALTH CARE; FEMALE; HUMANS; INCIDENCE; MALE; PREVALENCE; REGISTRIES; RISK FACTORS; SECONDARY PREVENTION; SEX FACTORS; STROKE;

EID: 84856230838     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.635755     Document Type: Article

References (14)

1. Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modeling. Lancet Neurol. 2009;8:345-354.
2. Chen Z. The mortality and death cause of national sample areas. In: Chen Z, ed. The Third National Survey on the Cause of Death, I ed. Beijing: Peking Union Medical University Press; 2008:14-15.
3. Zhao YZ, Yao ZP, D'Souza W, Zhu C, Chun H, Zhuoga C, et al. An epidemiological survey of stroke in Lhasa, Tibet, China. Stroke. 2010;41:2739-2743.
4. Hu XL, Gong XG. The economic burden of ischemic stroke in China. China Healthcare Economy. 2003;22:18-20.
5. Ministry of Health PRC. 2010 Annual Chinese Healthcare Statistics. Beijing: China Union Medical University Publication; 2010.
6. Wang YL, Wu D, Wang YJ. Survey on acute cerebrovascular events care in China. Int J Stroke. 2006;2:56-57.
7. Liu M, Wu B, Wang WZ, Lee LM, Zhang SH, Kong LZ. Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol. 2007;6:456-464. (Pubitemid 46551849)
8. Zhao D, Liu J, Wang W, Zeng Z, Cheng J, Liu J, et al. Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Beijing Project. Stroke. 2008;39:1668-1674.
9. Wang YL, Wu D, Nguyen-Huynh MN, Zhou Y, Wang CX, Zhao XQ, et al. Prevention of Recurrences of Stroke Study in China Investigators. Antithrombotic management of ischaemic stroke and transient ischaemic attack in China: a consecutive cross-sectional survey. Clin Exp Pharmacol Physiol. 2010;37:775-781.
10. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376:112-123.
11. Wang Y, Cui L, Ji X, Dong Q, Zeng J, Wang Y, et al; on behalf of the investigators for the China National Stroke Registry (CNSR) investigators. The China National Stroke Registry for patients with acute cerebrovascular events: design, rationale, and baseline patient characteristics. Int J Stroke. 2011;6:355-361.
12. Wang YL, Liao XL, Zhao XQ, Wang DZ, Wang CX, Nguyen-Huynh MN, et al; on behalf of the China National Stroke Registry (CNSR) Investigators. Using recombinant tissue plasminogen activator to treat acute ischemic stroke in china analysis of the results from the Chinese National Stroke Registry (CNSR). Stroke. 2011;42:1658-1664.
13. Wang Y, Johnston SC; CHANCE Investigators. Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event. Am Heart J. 2010;160:380.e1-386.e1.
14. Jia Q, Liu LP, Wang YJ. Stroke in China. Clin Exp Pharmacol Physiol. 2010;37:259-264.